Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SMTC +13.8%, VRNT +9.2%, BRZE +8.3%, JBLU +7.8% (guidance), DG +3%, CIEN +3%, BASE +1.9%
Other news:
- ASLE +17.4% (receives Boeing 737NG Supplemental Type Certificate for its Enhanced Flight Vision System "AerAware")
- VNDA +16.6% (acquires U.S. and Canadian rights to PONVORY (ponesimod) from Johnson & Johnson's (JNJ) Actelion Pharmaceuticals)
- CERE +14.1% (ABBV to acquire CERE for $45/sh)
- ANIX +4.1% (Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine)
- AORT +3.8% (CFO retires names new CFO) CYTK +2.2% (presents results from COURAGE-ALS at the 34th International Symposium on ALS/MND)
- FSR +2.1% (issues statement says negative reports about co have been overblown)
- ASR +2% (reports Nov traffic)
- FWRD +1.7% (provides mid-quarter update)
- TRN +1.7% (increases dividend)
- DNA +1.5% (signs MoU with Synplogen to accelerate the development of DNA manufacturing and gene therapy in Japan)
- BHP +1.4% (CFO and executive leadership team update; Vandita Pant has been appointed Chief Financial Officer)
- PAX +1.2% (to acquire Credit Suisse's real estate business in Brazil for ~$130 mln)
- BMY +1.2% (increases dividend; announces additional $3 billion share repurchase authorization)
- LEV +1.2% (announced the successful final certification for its medium duty battery pack the LionBattery MD a lithium-ion battery pack specifically designed for the Company's medium duty trucks and school buses)
- CMPS +1.1% (study results of psilocybin published in JAMA Psychiatry)
Analyst comments:
- VTGN +14.2% (upgraded to Buy from Hold at Jefferies)
- BVS +5.3% (upgraded to Buy from Hold at Canaccord Genuity)
- EQNR +2.7% (upgraded to Buy from Neutral at BofA Securities)
- SPHR +2% (upgraded to Buy from Neutral at Seaport Research Partners)
- DDOG +1.5% (upgraded to Buy from Hold at Stifel)
- BIIB +1.1% (upgraded to Outperform from Mkt Perform at Raymond James)
- SNDR +1.1% (upgraded to Equal Weight from Underweight at Wells Fargo)